Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida

Introduction: The new direct acting antivirals (DAA) have demonstrated low rates of adverse effects in controlled studies. However, real world-studies have disclosed emerging toxicities and drug-drug interactions in special populations. Methods: We conducted a retrospective review of HIV/HCV coinfec...

Descripción completa

Detalles Bibliográficos
Autor principal: Gonzales Zamora, Jose Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023459/
https://www.ncbi.nlm.nih.gov/pubmed/29921760
http://dx.doi.org/10.3390/diseases6020051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023459/
https://www.ncbi.nlm.nih.gov/pubmed/29921760
http://dx.doi.org/10.3390/diseases6020051

Ejemplares similares